$MRNA Cashflow Statement | Understand Stock

$MRNA

$198.85 -$1.25 (0.62%) Close

$MRNA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Leased assets expensed
Depreciation and amortization
Amortization/accretion of investments
Loss on equity investments, net
Deferred income taxes
Other non-cash items
Changes in assets and liabilities:
Accounts receivable, net
Prepaid expenses and other assets
Inventory
Right-of-use assets, operating leases
Accounts payable
Accrued liabilities
Deferred revenue
Income taxes payable
Operating lease liabilities
Other liabilities

Net cash used in operating activities
Investing activities
Purchases of marketable securities
Proceeds from maturities of marketable securities
Proceeds from sales of marketable securities
Purchases of property, plant and equipment
Acquisition of business, net of cash acquired
Purchase of intangible asset
Investment in convertible notes and equity securities
Net cash provided by investing activities
Financing activities
Proceeds from offerings of common stock, net of issuance costs
Proceeds from credit facility
Payment of credit facility issuance costs
Proceeds from issuance of common stock through equity plans
Tax payments related to net share settlements on equity awards
Changes in financing lease liabilities
Net cash provided by (used in) financing activities

Effect of changes in exchange rates on cash and cash equivalents
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of year
Cash, cash equivalents and restricted cash, end of year
Supplemental cash flow information
Cash paid (received) for income taxes
Cash paid for interest
Non-cash investing and financing activities
Purchases of property, plant and equipment included in accounts payable and accrued liabilities

Comments